MARY STATON: Open Payments
NPI 1154528313 · TULARE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$970 in 44 payments from 15 companies in 2025. Trend: 2023 $1,976 · 2024 $1,456 · 2025 $970
Food & beverage: $970
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $187 |
| Amgen Inc. | 8 | $171 |
| ABBVIE INC. | 4 | $78 |
| Dexcom, Inc. | 3 | $69 |
| Alexion Pharmaceuticals, Inc. | 2 | $65 |
| Mannkind Corporation | 2 | $60 |
| Abbott Laboratories | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $54 |
| Radius Health, Inc. | 2 | $42 |
| Medtronic, Inc. | 2 | $37 |
Products named: Ozempic, TEPEZZA, SYNTHROID, Dexcom G6 Transmitter, STRENSIQ, AFREZZA, FREESTYLE LIBRE 3, REPATHA.
Industry payments across CA — which companies pay providers there.
